The position to be taken on behalf of the European Union within the Council for Trade-Related Aspects of Intellectual Property Rights and the General Council of the World Trade Organisation (‘WTO’), shall be the following:
(a)
to agree to:
(i)
the request from least-developed country (‘LDC’) Members for an extension of the transitional period under paragraph 1 of Article 66 of the Agreement on Trade-Related Aspects of Intellectual Property Rights (the ‘TRIPS Agreement’) concerning certain obligations related to pharmaceutical products; and
(ii)
the request to waive the obligations of LDC Members under paragraphs 8 and 9 of Article 70 of the TRIPS Agreement; and
(b)
to agree either to:
(i)
the request for the extension referred to in point (a)(i) of this Article, or the waiver referred to in point (a)(ii) of this Article, or both, to apply for as long as each LDC Member remains an LDC; or
(ii)
the request for a temporary extension or a temporary waiver, or both, if that request is also acceptable to the other WTO Members.